Incyte Corp
NASDAQ:INCY
$16.96
-$0.26
(-1.51%)
Quote as of 4:00 PM EST on 02/10/12
Extended Hours:
$16.96
$0.00
(0.00%)
Quote as of 4:41 PM EST on 02/10/12 (NASDAQ)
|
$16.96
-$0.26
(-1.51%)
|
|
| Today's Open | $17.11 |
|---|---|
| Previous Close | $17.22 |
| Daily Range | $16.90 - $17.30 |
| 52-Week Range | $11.76 - $21.15 |
| Market Cap | $2.14B |
| P/E Ratio | -22.08 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 835,323 |
| Average Daily Volume | 1,805,710 |
| Current FY EPS | -$1.45 |
INCY Information
| Description |
|---|
| The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Incyte in Neutral Lane - Analyst Blog
Do the Shorts Know Something You Don't?
JPMorgan Confab Kicks Off Biotech 2012
YM Biosciences Rises on Promising Study Data for Blood Drug
You're Not the Only One Buying Here
Applications Given Early Antitrust Clearance
Wall Street's Best Hidden Stocks
2 Stocks Approaching Greatness
